Gayer Charles K - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Gayer Charles K
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-05-13
Purchase
2024-05-15
07:04 am
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
Chief Commercial Officer
30,000$5.47$164,100307,533
(Direct)
View
2022-12-15
Sale
2022-12-19
4:48 pm
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
Chief Commercial Officer
6,100$10.9$66,490211,610
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-12-19
Tax Withholding
2025-12-23
4:08 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
President and CCO
11,477$7.41969,992
(Direct)
View
2025-12-22
Exercise
2025-12-23
4:08 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
President and CCO
50,000$5.51969,992
(Direct)
View
2025-12-22
Exercise
2025-12-23
4:08 pm
2017-05-23
2026-05-23
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
President and CCO
74,233$0969,992
(Direct)
View
2025-12-22
Exercise
2025-12-23
4:08 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
President and CCO
14,142$3.22969,992
(Direct)
View
2025-12-22
Exercise
2025-12-23
4:08 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
President and CCO
10,091$5.04969,992
(Direct)
View
2025-12-17
Option Award
2025-12-19
4:20 pm
2026-12-17
2035-12-17
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
President and CCO
1,457,950$01,876,777
(Direct)
View
2025-12-12
Tax Withholding
2025-12-16
4:21 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
President and CCO
8,181$7.57418,827
(Direct)
View
2024-12-19
Tax Withholding
2024-12-23
4:19 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
Chief Commercial Officer
2,461$7.39684,496
(Direct)
View
2024-12-19
Option Award
2024-12-23
4:19 pm
2025-12-19
2034-12-19
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
Chief Commercial Officer
386,900$0684,496
(Direct)
View
2024-12-14
Tax Withholding
2024-12-17
4:22 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
Chief Commercial Officer
8,251$7.53300,057
(Direct)
View
2023-12-19
Tax Withholding
2023-12-20
4:38 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
Chief Commercial Officer
2,482$6.05274,533
(Direct)
View
2023-12-14
Tax Withholding
2023-12-18
4:40 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
Chief Commercial Officer
5,840$6.43435,515
(Direct)
View
2023-12-14
Option Award
2023-12-18
4:40 pm
2024-12-14
2033-12-14
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
Chief Commercial Officer
192,500$0435,515
(Direct)
View
2022-12-19
Option Award
2022-12-21
4:34 pm
2023-12-19
2032-12-19
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
Chief Commercial Officer
192,500$0404,110
(Direct)
View
2021-12-14
Option Award(A)
2022-01-13
4:38 pm
N/A
N/A
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
Chief Commercial Officer
80,000$0216,556
(Direct)
View
2021-12-14
Option Award
2021-12-16
5:12 pm
2022-12-14
2031-12-14
BIOCRYST PHARMACEUTICALS INCBCRXGayer Charles K
Chief Commercial Officer
289,000$0425,556
(Direct)
View
(A) Indicate amendment filing.